Keywords: Iron Deficiency Anemia; Iron Overload; Intestinal Iron Absorption; Non-Transferrin Bound Iron; CP; ceruloplasmin; Cp-/-; mice lacking CP in the whole body; DAB; 3,3â²-diaminobenzidine; FDR; false discovery rate; FPN1; ferroportin 1; GI; gastrointestinal;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Pregnancy; Hypertension; Iron overload; Inflammation; Case-control study; ALP; alkaline phosphatase; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CRP; C-reactive protein; DHR; dihydrorhodamine 123; ELISA; enzyme-linked immunosorbent ass
Keywords: TfR1; transferrin receptor 1; Dmt1; divalent metal transporter 1; HIF-1α; hypoxia-inducible factor; IRP; iron regulatory protein; LIP; labile iron pool; FTH; ferritin heavy chain; FTL; ferritin light chain; Fpn1; ferroportin-1; Lcn2; lipocalin-2; 2; 5-DH
Keywords: AI; anaemia of inflammation; ARE; anti-oxidant responsive element; ATP; adenosine triphosphate; Bmp; bone morphogenetic protein; CD; cluster of differentiation; C/EBP; CCAAT enhancer-binding protein; CO; carbon monoxide; CREB; cyclic adenosine monophospha
Keywords: ACSL4; acyl-CoA synthetase long-chain family member 4; AD; Alzheimer's disease; ARE; antioxidant-responsive element; ANT; adenine nucleotide translocase; AP-1; activator protein-1; ATP; adenosine triphosphate; Bak; Bcl-2 antagonist/killer; BCEC; brain c
Keywords: GDF11; growth differentiation factor 11; LCI; labile cellular iron; NTBI; non-transferrin-bound iron; Erythropoiesis; Hematopoiesis; Iron; Myelodysplastic syndrome; Reactive oxygen species; Chelation therapy;
Keywords: Asc; ascorbic acid; Asc Ox; ascorbic acid oxidase; AscH-; ascorbate anion; Asc2-; ascorbate dianion; AscHâ¢; ascorbyl radical; AFR or Asc.-; ascorbate radical; Cat.; catalase; CL; chemiluminescence; DHA; dehydroascorbate; EPR; electron paramagnetic reson
Keywords: AC; accession number of protein in Swiss-prot database; ANOVA; one-way analysis of variance; ATP; adenosine triphosphate; BH; biotin hydrazide; DNPH; dinitrophenylhydrazine; EDTA; ethylenediamine tetraacetic acid; LC-MS/MS; tandem mass spectrometry; MDA;
Keywords: Brain iron; In vitro models of brain iron accumulation; Iron reagents; Iron quantification; Iron regulatory proteins; Serum and iron; Ascorbic acid and iron; Ferrozine assay; Organotypic brain slice cultures; Iron loading studies in primary neurons; Iron
Keywords: Fe3Â +; Â Ferric ion; Fe+Â 2; ferrous ion; GI; gastrointestinal tract; LIP; Labile Iron Pool (LIP); NBIA; neurodegeneration with brain iron accumulation; NTBI; Non-Transferrin Bound Iron; PCD; programmed cell death; RBC; red blood cell; RCD; Regulated cel
Keywords: α-syn; alpha synuclein; Tf; transferrin; TfR; transferrin receptor; DA; dopamine; PD; Parkinson's disease; Tf-Fe; transferrin bound iron; NTBI; non transferrin bound iron; SN; substantia nigra; RPE; retinal pigment epithelium; OCT; optical coherence tomo
Keywords: BBB; blood-brain barrier; DAB; 3,3â²-diaminobenzidine tetrahydrochloride; iNOS; inducible nitric oxide synthetase; KPBS; potassium phosphate-buffered saline; NBIA; neurodegeneration with brain iron accumulation; NO; nitric oxide; NTBI; non-transferrin
Keywords: β2M; beta 2-microglobulin; aa; amino acid; ACD; anemia of chronic diseases; BMP; bone morphogenetic protein; BMPR; bone morphogenetic protein receptor; CD; cluster of differentiation; Cp; ceruloplasmin; DcytB; duodenal cytochrome b; Dmt1; proton-coupled
Keywords: ALD; alcoholic liver disease; DMT1; divalent metal transporter 1; Ft; ferritin; HIF-1/2α; hypoxia-inducible factor-1/2 alpha; LIP-Fe; labile iron pool-Fe; NTBI; non-transferrin bound iron; PKA; protein kinase A; TfR1; transferrin receptor 1; TRPML1; tran
Keywords: Iron overload; Pathophysiology; Mechanism; Thalassemia; Sickle cell disease; Blood transfusion; NTBI; Extra-hepatic iron distribution;
Keywords: NTBI; non-transferrin-bound-iron; TRP; transient receptor potential; DMT1; divalent metal transporter 1; BBB; blood-brain barrier; Tf; transferrin; TfR1; transferrin receptor 1; TBI; Tf-bound iron; FAS; ferrous ammonium sulfate; FAC; ferric ammonium cit
Keywords: ACD; anemia of chronic disease; AID; absolute iron deficiency; ARE; antioxidant-responsive elements; asc; ascorbic acid; DMT1; divalent metal transporter 1; eNOS; endothelial nitric oxide synthase; EPO; erythropoietin; FBXL5; F-box and leucine-rich repeat
Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca2+ regulation in iron-overloaded thalassemic mice
Keywords: ATP; adenosine triphosphate; [Ca2+]i; intracellular calcium; CICR; calcium-induced calcium release; DFP; deferiprone; EF; ejection fraction; EFO; efonidipine; FE; iron diet; FS; fraction shortening; HRV; heart rate variability; HT; β-thalassemic type; IC
R2*-relaxometry of the pancreas in patients with human hemochromatosis protein associated hereditary hemochromatosis
Keywords: MRI; magnetic resonance imaging; LIC; liver iron concentration; HHC; hereditary hemochromatosis; HFE; human hemochromatosis protein; ROI; region of interest; NTBI; non-transferrin-bound iron; Pancreas; Iron; Hereditary hemochromatosis; Relaxometry;
Worse Outcomes of Patients With HFE Hemochromatosis With Persistent Increases in Transferrin Saturation During Maintenance Therapy
Keywords: Arthropathy; Iron Regulation; Hepcidin Deficiency; Treatment; BMI; body mass index; FRT50exp; exposure duration to serum ferritin â¥50 μg/L; NTBI; nontransferrin bound iron; SAT50exp; exposure duration to transferrin saturation â¥50%;
A combination of an iron chelator with an antioxidant effectively diminishes the dendritic loss, tau-hyperphosphorylation, amyloids-β accumulation and brain mitochondrial dynamic disruption in rats with chronic iron-overload
Keywords: AD; Alzheimer's disease; APP; amyloid precursor protein; Aβ; amyloid-β; BBB; blood-brain barrier; DFO; deferoxamine; DFP; deferiprone; DFX; deferasirox; Drp1; dynamin-related protein 1; HFe; high-iron diet; Mfn2; mitofusin2; NAC; n-acetyl cysteine;
Pre-treatment of rats with ad-hepcidin prevents iron-induced oxidative stress in the brain
Keywords: AD; Alzheimer's disease; Ad-Hepcidin; the recombinated-hepcidin-adenovirus; BBB; brain-blood barrier; BMECs; brain microvascular endothelial cells; DMT1; divalent metal transporter 1; Fpn1; ferroportin 1; GFAAS; graphite furnace atomic absorption spec
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: Kinetics of its appearance and potential predictive role in infectious complications
Keywords: NTBI; Non transferrin bound iron; Acute leukemia; Transfusional iron overload; Chemotherapy
PKA-mediated phosphorylation of Dexras1 suppresses iron trafficking by inhibiting S-nitrosylation
Keywords: NO; nitric oxide; PKA; protein kinase A; PTM; post translational modification; ACBD3; Acyl-CoA Binding Protein 3; GST; Glutathione-S-transferase; NTBI; Non-transferrin bound iron; Iron; Nitric oxide; S-nitrosylation; Phosphorylation; Neuron; Post-translat
Prion protein functions as a ferrireductase partner for ZIP14 and DMT1
Keywords: Dcytb; duodenal cytochrome b; DMT1; divalent metal transporter-1; FAC; ferric ammonium citrate; FR; ferrireductase; GFP; Green-fluorescent protein; ip; intraperitoneal; LIP; labile iron pool; NTBI; non-transferrin-bound iron; PrPC; prion protein; SDS-PAGE
Metabolically programmed iron chelators
Keywords: NTBI; nontransferrin-bound iron; DFO; desferrioxamine; sc; subcutaneously; DFT; desferrithiocin; DADFT; desazadesferrithiocin; s.i.d.; once daily; b.i.d.; twice daily; BUN; blood urea nitrogen; SCr; serum creatinine; GI; gastrointestinal; ICE; iron cleari
The active role of vitamin C in mammalian iron metabolism: Much more than just enhanced iron absorption!
Keywords: Asc; l--ascorbate; CGcytb; chromaffin granule cytochrome b561; Dcytb; duodenal cytochrome b561; DHA; dehydroascorbate; DMT1; divalent metal transporter isoform 1; FBXL5; F-box and leucine-rich repeat protein 5; FIH; factor inhibiting HIF; FPN1; ferroporti
PKA modulates iron trafficking in the striatum via small GTPase, Rhes
Keywords: λ PPase; λ phosphatase; A173V; alanine-173 valine; DMT1; divalent metal transporter 1; EDTA; ethylenediaminetetraacetic acid; G31V; glycine-31 valine; GEF; guanidine exchange factor; GTP; guanosine-5â²-triphosphate; GST; glutathione S-transferase; HRP;
Research ArticleNeonatal iron overload and tissue siderosis due to gestational alloimmune liver disease
Keywords: NH; neonatal hemochromatosis phenotype; GALD; gestational alloimmune liver disease; NTBI; non-transferrin-bound iron; TFR1; transferrin receptor-1; TFR2; transferrin receptor-2; DMT1; divalent metal transporter-1; ZIP14; solute carrier family 39 (zinc tra
Diagnostic value of transferrin
Keywords: AASLD; American Association for the Study of Liver Diseases; CHD; Coronary heart disease; CI; Confidence interval; CKD; Chronic kidney disease; DM; Diabetes mellitus; EASL; European Association for the Study of the Liver; ESA; Erythropoiesis-stimulating a
Effects of hypoxic preconditioning on the expression of iron influx and efflux proteins in primary neuron culture
Keywords: Cp; ceruloplasmin; DMEM; Dulbecco's modified Eagle's medium; DMT1; divalent metal transporter 1; DMT1Â +Â IRE; divalent metal transporter 1 with iron response element; DMT1âIRE; divalent metal transporter 1 without iron response element; FBS; fetal
FbpA - A bacterial transferrin with more to offer
Keywords: ABC; ATP-binding cassette; FbpA; Ferric binding protein A from N. gonorrhoeae unless otherwise noted; Fbp; Ferric binding protein: designates the generic class of Fbp proteins as opposed to a specific FbpA; FbpB/C; ABC transporter that recognizes FbpA and
Interference of deferasirox with assays for serum iron and serum unsaturated iron binding capacity during iron chelating therapy
Keywords: DFX; deferasirox; sFe; serum iron; UIBC; unsaturated iron binding capacity; DFX-Fe; DFX-iron complex; NTBI; non-transferrin-bound iron; Tf; transferrin; CPBA; competitive protein-binding analysis; Abs; absorbance; Deferasirox; Serum iron; Unsaturated iron
Effects of carboxylic acids on the uptake of non-transferrin-bound iron by astrocytes
Keywords: CSF, cerebrospinal fluid; DMT1, divalent metal transporter 1; FIC, ferricyanide; FOC, ferrocyanide; IB, incubation buffer; LDH, lactate dehydrogenase; NTBI, non-transferrin-bound ironCitric acid; Malic acid; NTBI; Neurodegeneration; Tartaric acid
Iron metabolism in macrophages from HFE hemochromatosis patients
Keywords: TfR; transferrin receptor; Tf; transferrin; NTBI; non-transferrin bound iron; FeCi; Fe(III) ammonium citrate; EPO; erythropoietin; C282Y mutation; Iron overload; Homeostasis;
Fluorescence assay of non-transferrin-bound iron in thalassemic sera using bacterial siderophore
Keywords: Transferrin; NTBI; Fluorescence; Azotobactin; Thalassemia
Ascorbyl free radical reflects catalytically active iron after intravenous iron saccharate injection
Keywords: AFR; ascorbyl free radical; NTBI; non-transferrin-bound iron; TIBC; total iron-binding capacity; ESR; electron spin resonance; hCRP; high sensitivity C-reactive protein; BDC-LDL; basal diene-conjugated low-density lipoprotein; DFO; desferrioxamine; TEAC;
Iron responses in hepatic, intestinal and macrophage/monocyte cell lines under different culture conditions
Keywords: Iron responses; Holo-transferrin; NTBI; Quantitative RT-PCR; Cell culture conditions
Results of an international round robin for the quantification of serum non-transferrin-bound iron: Need for defining standardization and a clinically relevant isoform
Keywords: NTBI; Non-transferrin-bound iron; Round robin; Iron overload; Chelator; Bleomycin;
Oxidative stress precedes peak systemic inflammatory response in pediatric patients undergoing cardiopulmonary bypass operation
Keywords: CPB; cardiopulmonary bypass; CRP; C-reactive protein; DHA; dehydroascorbic acid; GSH; reduced glutathione; GSSG, oxidized glutathione; HCT; hematocrit; HPLC; high-performance liquid chromatography; IL; interleukin; MDA; malondialdehyde; NAC; N-acetylcyste